Clinical Trial Update: Glutamate, Learning, and Working Memory [Phase 1]

View source ↗

Summary

A Phase 1 UCLA clinical trial investigating how glutamate influences learning and working memory in schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: University of California, Los Angeles | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED